gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.

MLA

Murray, Gerald L., et al. “GyrA Mutations in Mycoplasma Genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 76, no. 12, June 2023, pp. 2187–95. EBSCOhost, https://doi.org/10.1093/cid/ciad057.

APA

Murray, G. L., Plummer, E. L., Bodiyabadu, K., Vodstrcil, L. A., Huaman, J. L., Danielewski, J. A., Chua, T. P., Machalek, D. A., Garland, S., Doyle, M., Sweeney, E. L., Whiley, D. M., & Bradshaw, C. S. (2023). gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 76(12), 2187–2195. https://doi.org/10.1093/cid/ciad057

Chicago

Murray, Gerald L, Erica L Plummer, Kaveesha Bodiyabadu, Lenka A Vodstrcil, Jose L Huaman, Jennifer A Danielewski, Teck Phui Chua, et al. 2023. “GyrA Mutations in Mycoplasma Genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 76 (12): 2187–95. doi:10.1093/cid/ciad057.